| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59fe2710acf9ea1d6d104d37f9755810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b10cef65aa5754546d2b496ded94e30b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213ebab4ff556c3a8d347d340ccb62bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7f68db0eca89cfaf3fe3936e9035edd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-163 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
1999-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5ce74807f07f07f9712cc72ccdf947e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6cca0400d3ae2a6572af48bdb44cf68 |
| publicationDate |
2000-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0011225-A9 |
| titleOfInvention |
Method for determining prognosis of hiv infected individuals |
| abstract |
The serum levels of anti-tat antibodies, tat protein, and p24 protein are predictive of disease progression in HIV infected individuals and serve as prognostic markers. The present invention relates to a method for determining the prognosis of an HIV infected individual by measuring serum levels of one or more of these prognostic markers. In addition, a method for monitoring whether an HIV infected individual is in need of immunization with a tat vaccine and a method for monitoring the efficacy of immunization with a tat vaccine are also disclosed. |
| priorityDate |
1998-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |